News
CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, ...
CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...
A law firm has filed a class-action lawsuit, accusing CVS of using patient information to send political texts ...
Lawsuits were filed against CVS and its pharmacy benefit manager, accusing them of unfair practices and illegal lobbying.
CVS Caremark to pay $95M in Medicare fraud case A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs.
4d
Cryptopolitan on MSNMeta shareholders test boundaries as they drag Zuckerberg and top board members to courtMeta’s executives will meet in a Delaware court starting Wednesday over a lawsuit filed by three minority shareholders who ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
Louisiana’s attorney general accuses CVS and Caremark of using patient data to push legislation and inflating drug prices, harming patients and local pharmacies.
Through Aetna, CVS designs and manages plans that use Caremark as the PBM and CVS as the pharmacy. Aetna operates in Louisiana across multiple plan types, including: Medicaid, Medicare, individual ...
CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results